title: Priorities for improving drug research, development and regulation.
authors.affiliation: Scientific, Regulatory and Manufacturing Policy Committee, European Federation of Pharmaceutical Industries and Associations.
authors.forename: Susan R
authors.initials: SR
authors.lastname: Forda
authors.forename: Richard
authors.initials: R
authors.lastname: Bergström
authors.forename: Magda
authors.initials: M
authors.lastname: Chlebus
authors.forename: Richard
authors.initials: R
authors.lastname: Barker
authors.forename: Peter Høngaard
authors.initials: PH
authors.lastname: Andersen
mesh_terms: D015195:Drug Design; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000458:organization & administration* / Q000592:standards; D005060:Europe; D006801:Humans; D017146:Models, Organizational; D012106:Research / Q000331:legislation & jurisprudence / Q000458:organization & administration* / Q000592:standards
references.citation: Nat Rev Drug Discov. 2009 Dec;8(12):949-57
references.pmid: 19816458
references.citation: Nat Rev Drug Discov. 2011 Aug 31;10(9):641-2
references.pmid: 21878965
references.citation: Nat Rev Drug Discov. 2012 Jun 29;11(7):501-2
references.pmid: 22743964